Not Every Patient Is a Candidate for GLP-1 Therapy: What Physicians Evaluate Before Prescribing
The conversation around GLP-1 receptor agonists in recent years has been dominated, understandably, by what these medications can do for people who respond well to them. The results are genuinely remarkable, and the enthusiasm in both clinical circles and the general public reflects real outcomes in real patients. But enthusiasm for a drug class, however […]




















